Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Gland Surgery|January 19, 2023
Effect of the HER-2/CEP17 ratio in IHC 2+/FISH-amplified breast cancer on pathological complete response to neoadjuvant pertuzumab and trastuzumab treatment-a retrospective cohort studyJiabin Wang, Jianghua Qiao, Yuxia Ruan, et al.
Journal of Cellular and Molecular Medicine|August 4, 2024
Identification of prostate cancer bone metastasis related genes and potential therapy targets by bioinformatics and in vitro experimentsHaiyang Jiang, Mingcheng Liu, Yingfei Deng, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 16, 2023
A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib TherapyHanzhao Yang, Yadong Sun, Peili Wang, et al.
Frontiers in Oncology|March 2, 2026
Machine learning approaches for predicting progression in hormone-sensitive prostate cancer patientsBingyu Zhu, Haiyang Jiang, Chongjian Zhang, et al.
Cancers|September 23, 2022
Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy RegimenJiujun Zhu, Dechuang Jiao, Chengzheng Wang, et al.
Nature Communications|October 7, 2023
Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trialMin Yan, Limin Niu, Huimin Lv, et al.
Breast (Edinburgh, Scotland)|April 7, 2026
Global patterns and risk factors of breast cancer in women under 35: a population-based studyDechuang Jiao, Jiujun Zhu, Dandan Wang, et al.
Scientific Reports|October 28, 2024
Machine learning discrimination of Gleason scores below GG3 and above GG4 for HSPC patients diagnosisBingyu Zhu, Longguo Dai, Huijian Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2025
Application of Neoadjuvant Docetaxel Plus Cisplatin in Early-Stage Triple-Negative Breast Cancer (HELEN-001): Results from a Phase II TrialDechuang Jiao, Jianghua Qiao, Xianfu Sun, et al.
Frontiers in Oncology|May 17, 2021
Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast CancerJiujun Zhu, Dechuang Jiao, Min Yan, et al.
Pageof 4